Page results
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
Latest news and developments in the Macmillan Support and Information Service
-
Information about staff who work in the Macmillan Support and Information Service.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
Bones marrow harvest patient information page.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
File results
-
FOI/2021/0322 - Incidence and treatment of breast cancer
-
FOI/2021/0326 - International recruitment
-
FOI/2021/0327 - Occupational health physiotheray services
-
FOI/2021/0330 - Sexual assault related incidents
-
FOI/2021/0332 - Trust Policy for Information Governance
-
FOI/2021/0333 - Mental health patient complaints
-
FOI/2021/0339 - Defibrotide for the treatment of hepatic veno-occlusive disease
-
FOI/2021/0341 - Total hospital deaths (all causes)
-
FOI/2021/0343 - Hospital admissions and deaths
-
FOI/2021/0345 - Maternity unit closures